Entero Healthcare Solutions IPO: Entero Healthcare Solutions’ IPO is getting excellent response from the first day. The company is trying to raise Rs 1600 crore from the market. It has fresh stock worth Rs 1,000 crore.
The company told the stock exchange that it has offered 56,94,753 equity shares of face value Rs 10 to 25 anchor investors at the upper price band of Rs 1258 per equity share.
Entero Healthcare Solutions The allotment is likely to happen on 14th February. The last date to apply for this has been kept as 13th February.
According to Share Market Observer, shares of Entero Healthcare Solutions Limited are available in the gray market today at a premium of ₹126.
What is the status of IPO?
Entero Healthcare Solutions IPO has been subscribed 0.05 times till noon on the first day while its retail portion has been booked 0.22 times. The employees’ share in the public issue has been subscribed 0.17 times. The NII portion of the public issue has been booked 0.01 times. The company’s anchor investors include Capital Group, GIC, TT Emerging Markets Unconstrained Fund, Premji, Carmignac Portfolio, Amundi Funds New Silk Road, Amundi Funds Asia Equity Concentrated, Bajaj Allianz Life Insurance Company Limited, SBI General Insurance Limited, Jupiter India Fund, There is participation from many major investors.
What is the price band of IPO?
The price band of Entero Healthcare Solutions IPO has been fixed at ₹1195 to ₹1258 per equity share.
How much will the investor have to pay?
A lot size of the IPO is 11 equity shares and thereafter in multiples of 11 equity shares. This means that the investor will have to invest at least Rs 13,145 (1,195X11) at the minimum price and Rs 13,838 (1,258X11) at the maximum price. Whereas, the company is allowing retail investors to invest Rs 1,93,732 for a maximum of 154 equity shares.
When will the company be listed?
The company is likely to be listed on BSE and NSE on February 16.
What will the company do with the money?
The company has made a big plan regarding the funds received from IPO. Entero Healthcare Solutions will use the funds to finance its long-term working capital requirements for fiscal years 2025 and 2026. The funds left after repayment of loan will then be used to pursue inorganic growth through acquisitions and also for general corporate needs.